Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Looking for more hands-on support
Chronic inflammation is associated with many health problems
Structure's GLP-1 Pill Could Be Big, But Trial Results Will Confirm Structure Therapeutics Today GPCR Structure Therapeutics $49.12 -1.68 (-3.31%) As of 07/24/2026 04:00 PM Eastern 52-Week Range $15.80 $94.90 Price Target $110.55 Shares of Structure Therapeutics NASDAQ: GPCR have far outperformed both of the companies above in the last year, rising by over 150% during that time as investors have grown enthusiastic about aleniglipron, the firm's GLP-1 agonist candidate
Product Overview KLOW BLEND | 80mg (GHK-Cu 50mg, BPC-157 10mg, TB500 10mg, KPV 10mg) KLOW BLEND is an advanced, quad-compound research reagent formulated strictly for in vitro and animal model studies
US$ 28.35
US$ 24.73
US$ 24.27
US$ 22.91
US$ 27.51
![NOW Glutathione 500 mg 120 veg capsules [ Pack of 2 ]](https://i.ebayimg.com/images/g/yZ8AAOSwiV1mo-vI/s-l1200.jpg)
US$ 23.52
US$ 23.13
